Botanical species · safety record

Manilkara zapota

The EFSA Compendium of Botanicals holds 10 constituent measurements for Manilkara zapota. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Manilkara zapota (L.) P.Royen

10Constituent measurements
0Safety records
6Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Saponins2
  • Acetaldehyde1
  • Alkaloids1
  • Benzaldehyde1
  • Epigallocatechins1
  • Gallic acid1
  • Gallocatechin1
  • Hydroquinone1
  • Tannins1

Plant parts

  • Flower3
  • Fruit peel3
  • Fruit unspecified3
  • Seed1

Preparations

  • Solvent extraction8
  • Essential oil1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
BenzaldehydeFruit peelEssential oil2.2 PercentGC-MSResolve DOI
EpigallocatechinsFruit peelSolvent extractionHPLC with standard detection methodsResolve DOI
Gallic acidFruit unspecifiedSolvent extractionGC-MSResolve DOI
GallocatechinFruit peelSolvent extractionHPLC with standard detection methodsResolve DOI
HydroquinoneFruit unspecifiedSolvent extractionGC-MSResolve DOI
SaponinsSeedSolvent extractionResolve DOI
AcetaldehydeFruit unspecifiedGC-MSNo resolvable identifier
AlkaloidsFlowerSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
SaponinsFlowerSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
TanninsFlowerSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Das, Susmita., Dutta, Mainak., Chaudhury, Koel., De, Bratati. Metabolomic and chemometric study of Achras sapota L. fruit extracts for identification of metabolites contributing to the inhibition of alpha-amylase and alpha-glucosidase . European food research and technology, 2016, vol. 242, no. 5, p. 733-743. DOI
  2. Sumithra, P., Gricilda, Shoba F., Vimala, G., Sathya, J., Sankar, V., Saraswathi, R., Jayapriya, G. Anti-cancer activity of Annona squamosa and Manilkara zapota flower extract against MCF-7 cell line. Pharmacia sinica, 2014, vol. 5, no. 6), 98-10, p. 7 pp.
  3. SINGH, PDA., SIMON, OR., WEST, ME. ACUTE TOXICITY OF SEEDS OF THE SAPODILLA (ACHRAS-SAPOTA L). Toxicon, 1984, vol. 22, no. 1, p. 145-147. DOI
  4. Pino, J.A., Marbot, R., Aguero, J. Volatile components of sapodilla fruit (manilkara achras L.). Journal of essential oil research, 2003, vol. 15, no. 6, p. 374-375. DOI
  5. Laohakunjit, Natta., Kerdchoechuen, Orapin., Matta, Frank B., Silva, Juan L., Holmes, William E. Postharvest survey of volatile compounds in five tropical fruits using headspace-solid phase microextraction (HS-SPME) . Hortscience, 2007, vol. 42, no. 2, p. 309-314.
  6. Wang, Hongyu., Liu, Tingting., Song, Lixia., Huang, Dejian. Profiles and alpha-Amylase Inhibition Activity of Proanthocyanidins in Unripe Manilkara zapota (Chiku) . Journal of agricultural and food chemistry, 2012, vol. 60, no. 12, p. 3098-3104. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue